HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Up-regulated expression of cytoplasmic clusterin in human ovarian carcinoma.

AbstractBACKGROUND:
Recently, tumorigenic roles of the clusterin gene in several human malignancies have been suggested, but its potential role in the development and progression of ovarian carcinoma is unclear.
METHODS:
In the current study, immunohistochemistry was used to examine the expression status of clusterin in 10 normal ovaries, 20 ovarian cystadenomas, 15 borderline ovarian tumors, and 240 ovarian carcinomas (nonmetastatic and metastatic) by tissue microarray. In addition, the apoptotic index of each tumor was assessed with a terminal deoxyuridine triphosphate nick-end labeling assay.
RESULTS:
Positive staining for clusterin in different ovarian tissues was observed primarily a cytoplasmic pattern. Cytoplasmic overexpression of clusterin was detected in none of the normal ovaries, in 17% of cystadenomas, in 38% of borderline tumors, and in 58% of invasive ovarian carcinomas. A significant association was observed (P < 0.001) between the overexpression of clusterin and late clinical stage according to the International Federation of Gynecology and Obstetrics staging system. In addition, the overexpression of clusterin was detected more frequently in metastatic lesions than that in their matched primary tumors. The current results also provided evidence that the overexpression of cytoplasmic clusterin in carcinomas was correlated inversely with the tumors' apoptotic index, demonstrating an antiapoptotic function of cytoplasmic clusterin in ovarian carcinomas.
CONCLUSIONS:
The current results suggested that the overexpression of cytoplasmic clusterin may represent an acquired malignant phenotypic feature of ovarian carcinoma and may be one of the important factors in determining the aggressive nature of ovarian carcinoma.
AuthorsDan Xie, Sze Hang Lau, Jonathan S T Sham, Qiu-Liang Wu, Yan Fang, Li-Zhi Liang, Li-Hong Che, Yi-Xin Zeng, Xin-Yuan Guan
JournalCancer (Cancer) Vol. 103 Issue 2 Pg. 277-83 (Jan 15 2005) ISSN: 0008-543X [Print] United States
PMID15578711 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Copyright(c) 2004 American Cancer Society.
Chemical References
  • Biomarkers, Tumor
  • CLU protein, human
  • Clusterin
  • Glycoproteins
  • Molecular Chaperones
Topics
  • Adult
  • Aged
  • Biomarkers, Tumor (analysis)
  • Biopsy, Needle
  • Carcinoma (genetics, pathology)
  • Case-Control Studies
  • Chi-Square Distribution
  • Clusterin
  • Female
  • Gene Expression Regulation, Neoplastic
  • Glycoproteins (genetics, metabolism)
  • Humans
  • Immunohistochemistry
  • In Situ Nick-End Labeling
  • Middle Aged
  • Molecular Chaperones (genetics, metabolism)
  • Neoplasm Staging
  • Ovarian Neoplasms (genetics, pathology)
  • Probability
  • Prognosis
  • Reference Values
  • Sensitivity and Specificity
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: